IL79254A0 - Compositions for preventing graft rejection - Google Patents

Compositions for preventing graft rejection

Info

Publication number
IL79254A0
IL79254A0 IL79254A IL7925486A IL79254A0 IL 79254 A0 IL79254 A0 IL 79254A0 IL 79254 A IL79254 A IL 79254A IL 7925486 A IL7925486 A IL 7925486A IL 79254 A0 IL79254 A0 IL 79254A0
Authority
IL
Israel
Prior art keywords
heparin
compositions
graft rejection
humans
preventing graft
Prior art date
Application number
IL79254A
Other languages
English (en)
Original Assignee
Hadassah Med Org
Yeda Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to IL79254A priority Critical patent/IL79254A0/xx
Application filed by Hadassah Med Org, Yeda Res & Dev filed Critical Hadassah Med Org
Publication of IL79254A0 publication Critical patent/IL79254A0/xx
Priority to AT87108976T priority patent/ATE82502T1/de
Priority to ES87108976T priority patent/ES2052514T3/es
Priority to DE8787108976T priority patent/DE3782686T2/de
Priority to EP87108976A priority patent/EP0251134B1/fr
Priority to NO872675A priority patent/NO872675L/no
Priority to AU74706/87A priority patent/AU608228B2/en
Priority to DK331287A priority patent/DK169422B1/da
Priority to JP62159514A priority patent/JP2527749B2/ja
Priority to CA000540717A priority patent/CA1318591C/fr
Priority to US07/583,851 priority patent/US5206223A/en
Priority to GR930400069T priority patent/GR3006814T3/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Transplantation (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Soil Working Implements (AREA)
  • Paper (AREA)
  • Fertilizers (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL79254A 1986-06-26 1986-06-26 Compositions for preventing graft rejection IL79254A0 (en)

Priority Applications (12)

Application Number Priority Date Filing Date Title
IL79254A IL79254A0 (en) 1986-06-26 1986-06-26 Compositions for preventing graft rejection
AT87108976T ATE82502T1 (de) 1986-06-26 1987-06-23 Zusammensetzungen zur vorbeugung von plastikabstossung.
ES87108976T ES2052514T3 (es) 1986-06-26 1987-06-23 Un procedimiento para la preparacion de composiciones farmaceuticas eficaces contra enfermedades autoinmunes.
DE8787108976T DE3782686T2 (de) 1986-06-26 1987-06-23 Zusammensetzungen zur vorbeugung von plastik-abstossung.
EP87108976A EP0251134B1 (fr) 1986-06-26 1987-06-23 Compositions pour prévenir le rejet de la greffe
NO872675A NO872675L (no) 1986-06-26 1987-06-25 Middel for hemning av avstoetning av transplanterte organer
AU74706/87A AU608228B2 (en) 1986-06-26 1987-06-25 Compositions for preventing graft rejection
DK331287A DK169422B1 (da) 1986-06-26 1987-06-26 Anvendelse af heparin, N-desulfateret, N-acetyleret heparin eller O-desulfateret, N-acetyleret heparin til fremstilling af et farmaceutisk præparat, som er effektivt over for autoimmune sygdomme, til lindring af sådanne sygdomme og til behandling af autoimmune sygdomme i pattedyr, herunder mennesker, og til hindring eller forsinkelse af allotransplantatudstødelse
JP62159514A JP2527749B2 (ja) 1986-06-26 1987-06-26 移植拒否反応抑制または自己免疫疾患治療用薬学的組成物
CA000540717A CA1318591C (fr) 1986-06-26 1987-06-26 Composition contenant de l'heparine ou un derive de celle-ci
US07/583,851 US5206223A (en) 1986-06-26 1990-09-17 Method for inhibiting heparanase activity
GR930400069T GR3006814T3 (fr) 1986-06-26 1993-01-14

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IL79254A IL79254A0 (en) 1986-06-26 1986-06-26 Compositions for preventing graft rejection

Publications (1)

Publication Number Publication Date
IL79254A0 true IL79254A0 (en) 1986-09-30

Family

ID=11056896

Family Applications (1)

Application Number Title Priority Date Filing Date
IL79254A IL79254A0 (en) 1986-06-26 1986-06-26 Compositions for preventing graft rejection

Country Status (10)

Country Link
EP (1) EP0251134B1 (fr)
JP (1) JP2527749B2 (fr)
AT (1) ATE82502T1 (fr)
AU (1) AU608228B2 (fr)
DE (1) DE3782686T2 (fr)
DK (1) DK169422B1 (fr)
ES (1) ES2052514T3 (fr)
GR (1) GR3006814T3 (fr)
IL (1) IL79254A0 (fr)
NO (1) NO872675L (fr)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5541166A (en) * 1987-01-23 1996-07-30 The Australian National University Sulphated polysaccharides having anti-metastatic and/or anti-inflammatory activity
IL85145A (en) * 1987-01-23 1994-08-26 Univ Australian Anti-metastatic pharmacological or veterinary preparations containing modified herpin with reduced anticoagulant activity
GB8808810D0 (en) * 1988-04-14 1988-05-18 Biopharm Clinical Research Ltd Heparin-containing formulations
IL86753A0 (en) * 1988-06-15 1988-11-30 Hadassah Med Org Pharmaceutical compositions for treatment of lupus
DE3821271A1 (de) * 1988-06-23 1989-12-28 Solco Basel Ag Derivatisiertes heparin, verfahren zu dessen herstellung und arzneimittel, welches dieses enthaelt
IL88554A0 (en) * 1988-12-01 1989-07-31 Hadassah Med Org Compositions containing a compound binding to a heparin receptor
US5158940A (en) * 1990-02-14 1992-10-27 The United States Government As Represented By The Secretary, Dhhs Use of suramin to treat rheumatologic diseases
WO1999003493A1 (fr) * 1997-07-14 1999-01-28 Meiji Milk Products Co., Ltd. Medicaments contenant midkine en tant principe actif ou inhibiteurs desdits medicaments
US6538028B1 (en) 2000-02-01 2003-03-25 Vanderbilt University Method for inhibiting complement activation
CN1197587C (zh) * 2000-06-09 2005-04-20 中国科学院上海细胞生物学研究所 N－位脱硫酸肝素在预防和治疗炎症中的应用
CZ307433B6 (cs) 2001-09-12 2018-08-22 Leadiant Biosciences Sa Deriváty částečně desulfátovaných glykosaminoglykanů jako inhibitory heparanázy mající antiangiogenní účinky a zabraňující antikoagulačnímu působení
ES2399277T3 (es) 2004-05-27 2013-03-27 Baxter International Inc. Procedimiento de tratamiento de trastornos hemorrágicos utilizando polisacáridos sulfatados
WO2010020423A2 (fr) 2008-08-22 2010-02-25 Baxter Healthcare S.A. Méthodes de traitement de troubles du saignement
JP6393453B2 (ja) 2010-01-14 2018-09-19 バクスアルタ ゲーエムベーハー 出血性障害を治療するための方法及び組成物
EP2734213B1 (fr) 2011-07-19 2018-06-06 Baxalta GmbH Activateurs de résorption comme additifs pour améliorer la formulation orale de polysaccharides sulfatés non anticoagulants
EP2885642B1 (fr) 2012-08-14 2019-05-15 Baxalta GmbH Procédés et systèmes de criblage de compositions comprenant des polysaccharides sulfatés non coagulants
EP3578184A1 (fr) 2013-03-12 2019-12-11 Baxalta GmbH Activateurs de résorption utilisés comme additifs pour améliorer la formulation orale d'héparines à faible poids moléculaire
SE538503C2 (en) 2014-11-11 2016-08-16 Tx Medic Ab New dextran sulfate
WO2016198578A1 (fr) * 2015-06-11 2016-12-15 Universiteit Maastricht Procédé de prévention d'échec de greffe chez un hôte
JP2025516366A (ja) * 2022-05-06 2025-05-27 バージェント セラピューティクス プロプライエタリー リミテッド 同種移植拒絶反応の治療方法

Also Published As

Publication number Publication date
DE3782686T2 (de) 1993-06-09
ES2052514T3 (es) 1994-07-16
NO872675D0 (no) 1987-06-25
JPS6388127A (ja) 1988-04-19
JP2527749B2 (ja) 1996-08-28
AU608228B2 (en) 1991-03-28
DK169422B1 (da) 1994-10-31
NO872675L (no) 1987-12-28
GR3006814T3 (fr) 1993-06-30
DK331287A (da) 1987-12-27
EP0251134A2 (fr) 1988-01-07
DE3782686D1 (de) 1992-12-24
AU7470687A (en) 1988-01-07
EP0251134A3 (en) 1989-05-03
DK331287D0 (da) 1987-06-26
ATE82502T1 (de) 1992-12-15
EP0251134B1 (fr) 1992-11-19

Similar Documents

Publication Publication Date Title
EP0251134A3 (en) Compositions for preventing graft rejection
EP0184040A3 (en) Method and system for removing immunosuppressive components from the blood of mammals
ATE190496T1 (de) Behandlung von autoimmunkrankheiten durch verabreichung von autoantigenen in form von aerosol
GR79015B (fr)
ZA884936B (en) Edible plastic disperson
DE3167338D1 (en) Stabilisation of factor viii activity in blood plasma
NZ210275A (en) Modified hirudin and its antithrombin properties
ATE60924T1 (de) Verfahren zur kontrollierten herstellung von glykosaminoglykanen mit niedrigem molekulargewicht.
ES2137225T3 (es) Eliminacion de anticuerpos de composiciones de derivados sanguineos reteniendo los factores de coagulacion.
DE69435303D1 (de) Er behandlung von krankheiten bei denen eine cytok
EP0011651A4 (fr) Composition pharmaceutique contenant 3-oxo-2,3-dihydro-(1)-benzothiophène-2-spirocyclopropane te ce composé utilisable dans la prophylaxie ou le traitement des troubles cardio-vasculaires.
MY105522A (en) Composition for treating seeds.
DE3584560D1 (de) Arzneimittelzusammensetzung geeignet zur behandlung oder prophylaxe von herzstoerungen.
EP0376251A3 (en) An anticoagulant substance obtained from urine
ATE81467T1 (de) Immunosuppression bei der auf immunotoxin basierten behandlung von menschen.
PH27352A (en) 4-Benzyl-5-phenyl-2,4-dihydro-3h-1,2,4-triazol-3-ones and their use as anticonvulsants
WO1992004359A3 (fr) Monosaccharides presentant une activite anti-proliferative et anti-inflammatoire, compositions et leurs utilisations
GR3017358T3 (en) 5-Aryl-3H-1,2,4-triazol-3-ones and their use as anticonvulsants.
SE8802193L (sv) Utvaertes anvaendbar, antiviral farmaceutisk komposition som ackumuleras i huden samt foerfarande foer framsttaellning av densamma
DE3270466D1 (en) Pharmaceutical composition
IT8919204A0 (it) Composizione per la prevenzione e la cura di parodontopatte.